Psychopharmacology (Berl). 1987;91(1):104-8.

The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.

Abstract

Thirty chronic ambulatory schizophrenic patients whose main psychopathology was characterized by the persistence of negative symptoms, such as emotional withdrawal, depressed mood, motor retardation and blunted affect were included in this project in order to evaluate the therapeutic efficacy of tranylcypromine plus chlorpromazine therapy. The results show that tranylcypromine when added to the usual dose of chlorpromazine, in many instances, induces a definite improvement in these patients' clinical condition, that such treatment is safe and it may be also useful in preventing the occurrence of extra-pyramidal symptoms.

PMID:: 3103152; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

EBSCO

Medical

Schizophrenia - MedlinePlus Health Information

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study. [Hum Psychopharmacol. 2008]
Efficacy of selegiline add on therapy to risperidone in the treatment of the negative symptoms of schizophrenia: a double-blind randomized placebo-controlled study.
Amiri A, Noorbala AA, Nejatisafa AA, Ghoreishi A, Derakhshan MK, Khodaie-Ardakani MR, Hajiazim M, Raznahan M, Akhondzadeh S. Hum Psychopharmacol. 2008 Mar; 23(2):79-86.
[Acute schizophrenia concept and definition: investigation of a French psychiatrist population]. [Encephale. 2005]
[Acute schizophrenia concept and definition: investigation of a French psychiatrist population].
Baylé FJ, Misdrahi D, Llorca PM, Lançon C, Olivier V, Quintin P, Azorin JM. Encephale. 2005 Jan-Feb; 31(1 Pt 1):10-7.
Withdrawal symptoms after long-term treatment with low-potency neuroleptics. [J Clin Psychiatry. 1984]
Withdrawal symptoms after long-term treatment with low-potency neuroleptics.
Chouinard G, Bradwejn J, Annable L, Jones BD, Ross-Chouinard A. J Clin Psychiatry. 1984 Dec; 45(12):500-2.
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. [Encephale. 2005]
Review [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, et al. Encephale. 2005 Mar-Apr; 31(2):235-46.
Review [Use of antidepressant drugs in schizophrenic patients with depression]. [Encephale. 2006]
Review [Use of antidepressant drugs in schizophrenic patients with depression].
Micallef J, Fakra E, Blin O. Encephale. 2006 Mar-Apr; 32(2 Pt 1):263-9.

See reviews... See all...

Cited by 2 PubMed Central articles

Review Histone modifications, DNA methylation, and schizophrenia. [Neurosci Biobehav Rev. 2010]
Review Histone modifications, DNA methylation, and schizophrenia.
Gavin DP, Sharma RP. Neurosci Biobehav Rev. 2010 May; 34(6):882-8. Epub 2009 Oct 30.
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia. [J Dual Diagn. 2007]
Medications Development for the Treatment of Nicotine Dependence in Individuals with Schizophrenia.
Montoya ID, Vocci F. J Dual Diagn. 2007 Nov; 3(3-4):113-150.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.
The negative symptoms of schizophrenia and the monoamine oxidase inhibitors.
Psychopharmacology (Berl). 1987 ;91(1):104-8.

PubMed
Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induce...
Effect of OKY-046, a thromboxane A2 synthetase inhibitor, on arachidonate-induced platelet aggregation: possible role of "prostaglandin H2 steal" mechanism.
Jpn Circ J. 1986 Nov ;50(11):1071-8.

PubMed
Clavulanic acid, a novel inhibitor of beta-lactamases.
Clavulanic acid, a novel inhibitor of beta-lactamases.
Antimicrob Agents Chemother. 1978 Nov ;14(5):650-5.

PubMed
Theories of the etiology of multiple sclerosis: a critical review.
Theories of the etiology of multiple sclerosis: a critical review.
J Clin Lab Immunol. 1986 Oct ;21(2):55-70.

PubMed
The stimulus for bone formation.
The stimulus for bone formation.
Hip. 1987 :25-38.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: